Published in Virology on August 05, 2008
HIV-1 assembly in macrophages. Retrovirology (2010) 1.20
A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology (2009) 1.18
Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology (2009) 1.18
Relationships between plasma membrane microdomains and HIV-1 assembly. Biol Cell (2010) 1.16
Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells. J Virol (2009) 1.11
HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components. Traffic (2010) 1.11
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
The roles of tetraspanins in HIV-1 replication. Curr Top Microbiol Immunol (2009) 0.89
Dynamic Association between HIV-1 Gag and Membrane Domains. Mol Biol Int (2012) 0.84
A post-entry role for CD63 in early HIV-1 replication. Virology (2011) 0.84
Identification of cellular proteins required for replication of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2012) 0.84
Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells. J Virol (2015) 0.84
Rab27a controls HIV-1 assembly by regulating plasma membrane levels of phosphatidylinositol 4,5-bisphosphate. J Cell Biol (2015) 0.83
Antiretroviral therapy down-regulates innate antiviral response genes in patients with AIDS in sub-saharan Africa. J Acquir Immune Defic Syndr (2010) 0.81
The dual role of tetraspanin CD63 in HIV-1 replication. Virol J (2014) 0.81
The HIV-1 matrix protein does not interact directly with the protein interactive domain of AP-3δ. Virus Res (2012) 0.81
Tetraspanin CD63 is a regulator of HIV-1 replication. Int J Clin Exp Pathol (2015) 0.76
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 20.59
Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (1991) 8.80
Retrovirus budding. Annu Rev Cell Dev Biol (2004) 7.16
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol (2003) 4.68
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A (1999) 4.61
Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J (1988) 3.98
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol (1988) 3.45
Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic (2002) 3.39
Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J Virol (2004) 3.22
Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology (1997) 3.21
HIV infection does not require endocytosis of its receptor, CD4. Cell (1988) 2.88
Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol (1988) 2.80
HIV: early virus-cell interactions. J Acquir Immune Defic Syndr (1990) 2.71
Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol (2001) 2.67
Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J Virol (1992) 2.62
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol (1994) 2.36
Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest (1992) 2.28
Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol (2005) 2.12
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol (1996) 2.10
Endosomes, exosomes and Trojan viruses. Trends Microbiol (2004) 1.84
The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med (1991) 1.81
Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J Virol (2005) 1.77
Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol (1993) 1.71
The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol (1998) 1.69
Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J Immunol (1996) 1.54
Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr (1991) 1.54
HIV interaction with endosomes in macrophages and dendritic cells. Blood Cells Mol Dis (2005) 1.32
Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J Virol (2003) 1.28
Efficiency and fidelity of full-site integration reactions using recombinant simian immunodeficiency virus integrase. J Virol (1999) 0.97
Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry. J Clin Oncol (2012) 2.98
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. J Clin Oncol (2002) 2.75
Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol (2007) 2.12
Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. J Virol (2005) 1.77
Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma. J Clin Oncol (2003) 1.52
Pathway analysis reveals common pro-survival mechanisms of metyrapone and carbenoxolone after traumatic brain injury. PLoS One (2013) 1.44
Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes (2004) 1.33
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing. J Clin Microbiol (2009) 1.32
Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J Virol (2003) 1.28
Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes (2005) 1.26
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology (2008) 1.23
Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol (2007) 1.21
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial. Blood (2002) 1.20
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists. J Biol Chem (2003) 1.19
Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology (2007) 1.16
Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J (2002) 1.15
Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am J Trop Med Hyg (2008) 1.10
Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner. J Infect Dis (2003) 1.05
Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic (2006) 1.04
Host factors mediating HIV-1 replication. Virus Res (2011) 1.03
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One (2011) 1.02
Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure. J Acquir Immune Defic Syndr (2006) 1.01
Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand. J Acquir Immune Defic Syndr (2004) 0.98
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol (2004) 0.98
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer. Clin Cancer Res (2002) 0.98
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer. J Clin Oncol (2003) 0.97
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine. J Clin Oncol (2008) 0.96
Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers. Virology (2008) 0.96
Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase. Biochemistry (2005) 0.95
Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility. AIDS Res Hum Retroviruses (2008) 0.95
Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer. Cancer (2014) 0.91
Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype. Clin Cancer Res (2012) 0.91
Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development. PLoS Negl Trop Dis (2013) 0.91
Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Horm Cancer (2010) 0.89
Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells. J Virol (2006) 0.88
Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line. Virol J (2010) 0.88
Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial. J Cancer (2013) 0.88
Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer. Horm Cancer (2011) 0.87
Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues. Cancer Treat Rev (2004) 0.86
High resolution crystal structure of human Rab9 GTPase: a novel antiviral drug target. J Biol Chem (2004) 0.84
A functional role for ADAM10 in human immunodeficiency virus type-1 replication. Retrovirology (2011) 0.84
A post-entry role for CD63 in early HIV-1 replication. Virology (2011) 0.84
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer. Cancer Chemother Pharmacol (2012) 0.84
Identification of cellular proteins required for replication of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2012) 0.84
Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials. Expert Rev Vaccines (2011) 0.84
A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer. Clin Cancer Res (2003) 0.84
Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death. Cancer Res (2005) 0.83
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer (2011) 0.83
Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer. Cancer Immunol Immunother (2004) 0.82
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit. Arch Ophthalmol (2002) 0.82
Role of aldose reductase in TNF-alpha-induced apoptosis of vascular endothelial cells. Chem Biol Interact (2003) 0.82
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex. J Immunol (2002) 0.82
The dual role of tetraspanin CD63 in HIV-1 replication. Virol J (2014) 0.81
Discordance at human leukocyte antigen-DRB3 and protection from human immunodeficiency virus type 1 transmission. J Infect Dis (2002) 0.81
Delivery of double-stranded DNA thioaptamers into HIV-1 infected cells for antiviral activity. Biochem Biophys Res Commun (2006) 0.80
Localization of West Nile Virus in monkey brain: double staining antigens immunohistochemically of neurons, neuroglia cells and West Nile Virus. Int J Clin Exp Pathol (2009) 0.80
Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis. Antivir Chem Chemother (2012) 0.79
Gp120 in the pathogenesis of human immunodeficiency virus-associated pain. Ann Neurol (2014) 0.79
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer. Invest New Drugs (2015) 0.79
HIV-1 replication cycle. Clin Lab Med (2002) 0.78
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. J Interferon Cytokine Res (2002) 0.78
Therapeutic breast cancer vaccines: a new strategy for early-stage disease. BioDrugs (2009) 0.78
Clinical studies of vaccines targeting breast cancer. Clin Cancer Res (2003) 0.78
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome. Cancer (2004) 0.78
CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37). Expert Opin Biol Ther (2009) 0.78
Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients. AIDS (2002) 0.77
Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer. Cancer Invest (2002) 0.77
Pre-travel preparation for Cusco, Peru: a comparison between European and North American travelers. J Travel Med (2010) 0.76
Genotypic HIV-1 drug resistance testing in antiretroviral-naive subjects in Houston, Texas. J Acquir Immune Defic Syndr (2002) 0.76
Non-structural and nucleocapsid proteins of Punta Toro virus induce apoptosis of hepatocytes through both intrinsic and extrinsic pathways. Microbiol Immunol (2010) 0.76